Matthew Bowen insider trades

Open-market stock purchases and sales by Matthew Bowen, Principal Accounting Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Apr 6, 2026.

Recent trades

DateStockTradeValue
Oct 5, 2026GLUE Monte Rosa Therapeutics, IncSold$137
Apr 6, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Apr 6, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—

Companies traded

  • GLUE Monte Rosa Therapeutics, Inc: 1 sale, last Oct 5, 2026

Get free alerts when Matthew Bowen files a new trade →